COVID-19

Adults in British Columbia who are at high risk of severe outcomes from COVID-19 can continue to access the antiviral medication nirmatrelvir-ritonavir …

By Trish Greenhalgh, University of Oxford; C Raina MacIntyre, UNSW Sydney, and David Fisman, University of Toronto When a Texan farm worker …